The Pfizer laboratory will sell up to 4 million doses of its treatment against Covid-19 to Unicef. The United Nations Children’s Fund will be responsible for distributing Paxlovid tablets in 95 countries, mainly in Africa, which represent approximately 53% of the world’s population. “Low or middle-low income countries will be able to obtain treatments at cost price while middle-high income countries will pay according to the price grid defined by Pfizer”, details the press release, without specifying the amount of the payment. transaction.
The Paxlovid treatment is intended above all for populations at risk (very elderly, immunocompromised people, suffering from certain rare diseases, etc.). It reduces the risk of being hospitalized or dying from Covid by around 85%, according to clinical studies.
Last week, Pfizer struck licensing deals under the auspices of the United Nations, allowing 35 companies to manufacture a generic, less expensive version of these pills. The licenses have been awarded to 19 Indian laboratories, 5 Chinese, and the others are divided between Bangladesh, Brazil, the Dominican Republic, Jordan, Israel, Mexico, Pakistan, Serbia, South Korea and Vietnam .